All data underlying the findings in this study are freely available in the paper.

Introduction {#sec005}
============

Tuberculosis (TB) remains a public health challenge worldwide and particularly in Central Asian countries. TB is one of the main health priorities in Uzbekistan and since 2004 the DOTS (directly observed treatment, short course) strategy has been progressively rolled out in the country. A recent study conducted in Tashkent, the capital city of Uzbekistan, showed that, of 1087 pulmonary TB patients started on treatment in 2005, 228 (21%) were lost to follow up \[[@pone.0128907.ref001]\]. Treatment failure among TB patients in certain provinces in Uzbekistan has also been relatively high (over 5--8%), and the prevalence of multidrug resistant TB (MDR TB) among new cases has tended to increase over the years (Drug resistance survey---14.2% in 2005 and 23.2% in 2011), \[[@pone.0128907.ref002], [@pone.0128907.ref003], [@pone.0128907.ref004]\].

Given the high rate of unfavorable treatment outcomes reported in some provinces, there is a need to analyze unfavorable outcomes countrywide and identify possible trends and associated risk factors that could guide the National TB programme (NTP) in further improvements. The NTP uses an individual-patient electronic database and this therefore allows for detailed analysis beyond the conventional monitoring and evaluation reports that are reliant on aggregate data. All TB patients registered in electronic database were on first-line treatment regimen. Of the drugs, isoniazid (H), rifampin (R), ethambutol (E), and pyrazinamide (Z) are considered first-line anti-TB drugs and form the core of standard treatment regimens for drug susceptible TB patients

Using countrywide TB data from Uzbekistan on TB patients receiving first-line treatment, the aim of our research was to determine a) trends in lost to follow-up, deaths and treatment failures between 2006 and 2010 and b) the socio-demographic and clinical risk factors associated with each of these unfavorable treatment outcomes.

Methods {#sec006}
=======

Ethics {#sec007}
------

The study was approved by the "National Ethics Committee and Review Board" under the Ministry of Health (MoH) of Republic of Uzbekistan. The study satisfied the criteria for reports using routinely collected programmatic data set by the Médecins Sans Frontières Ethics Review Board (ERB), Geneva, Switzerland. Patient identifying information was removed prior to analysis. As this was a study of routinely collected monitoring data, patient consent was not required.

Study design {#sec008}
------------

This was a retrospective cohort study of routinely collected NTP data for all TB patients registered and commenced on first-line treatment between January 2006 and December 2010. All patients were followed up until the end of treatment (6--8 months) to ascertain treatment outcomes.

Study setting {#sec009}
-------------

Previously part of the former Soviet Union, Uzbekistan is a country in Central Asia with an estimated population of more than 30 million. The country is divided into twelve provinces, the Republic of Karakalpakstan and the metropolitan area of Tashkent, the capital city.

### The National TB Program (NTP) {#sec010}

TB control activities are coordinated countrywide by the Republican Specialized Scientific Practical Medical Center of Phthisiology and Pulmonology (RSSPMCPP), which is essentially the NTP. TB diagnosis and treatment are provided free of charge within the NTP--there are no private TB services. Nonetheless, first and second line anti-TB drugs are available on the open market as a result of there being no governmental regulations to forbid the selling of these drugs. All registered TB patients receive treatment in accordance with the Stop TB Strategy. The latest WHO Global TB Report \[[@pone.0128907.ref005]\] reports that only 35--50% of the national cases in Uzbekistan were detected between 2005 and 2010, implying that there may be a large number of TB cases left untreated or receiving 'unregistered' inefficacious treatments regimens in the country.

### TB diagnosis and treatment {#sec011}

An established TB laboratory network in the country includes two National Reference Laboratories (NRL), five bacteriological laboratories and more than 300 smear microscopy laboratories, the latter of which perform direct microscopy of sputum collected in primary healthcare facilities. The mainstay of TB diagnosis in most provinces in Uzbekistan was through sputum smear microscopy or X-ray investigations. In accord with national guidelines \[[@pone.0128907.ref006]\], TB type was categorized as either pulmonary TB (PTB) or extrapulmonary TB (EPTB). PTB was defined as TB lesions involving the lung parenchyma, while TB lesions of the intra-thoracic lymph nodes (mediastinal and /or hilar), or tuberculosis pleurisies in the absence of radiographic changes in the lungs, were considered to be EPTB. If a patient presented with PTB and EPTB, they were recorded as having PTB when the pulmonary TB lesions were prominent; if however the patient had severe EPTB lesions (e.g. tuberculous meningitis) with limited forms of PTB lesions (smear-negative PTB), the patient was recorded as having EPTB.

Drug susceptibility testing (DST) during the study period could only be performed in two laboratories in Tashkent and Nukus. DST was performed using solid and liquid culture media and line probe assay (LPA) tests to determine type of drug resistance. Quality control in the two laboratories was ensured through routine checks by the Supra National Reference Laboratories (SNRL) in Borstel and Gauting, Germany. During the study period MDR-TB treatment was only available in Tashkent city, Nukus and the penitentiary system, and on account of limited bed capacity and resources, access to such treatment was not available for people residing in other provinces.

At the provincial level, TB treatment is provided under the supervision of the MoH and NTP at TB hospitals; at the district level, TB treatment is overseen by the TB dispensaries (outpatient care during the intensive phase and/or continuation phase of treatment) and also at the primary health care level (continuation phase of treatment) for both drug susceptible and MDR-TB patients in pilot areas. The Global Fund to Fight AIDS, Tuberculosis and Malaria (The Global Fund) provides all first-line anti-TB drugs and, since 2013, has provided all second-line drugs countrywide for treatment of drug resistant tuberculosis (DR TB). A recent Drug Resistance Survey (DRS) showed high rates of MDR TB among new and previously treated patients, 23% and 62% respectively (3). In response to the high levels of MDR TB, the NTP developed the "Updated National Plan on prevention and control of M/XDR TB for 2012--2015 in Uzbekistan" \[[@pone.0128907.ref007]\] which is in line with the "The Consolidated Action Plan to Prevent and Combat Multidrug- and Extensively Drug-Resistant Tuberculosis in the WHO European Region, 2011--2015". This plan aims to decrease by 20 percentage points the proportion of MDR-TB among previously treated patients by the end of 2015; to diagnose at least 85% of all estimated MDR-TB patients by the end of 2015; to treat successfully at least 75% of all patients notified as having MDR-TB by the end of 2015. \[[@pone.0128907.ref008]\]

### NTP monitoring system {#sec012}

Since 2005, an Epi-Info based-TB-ESCM (Tuberculosis Electronic Surveillance and Case Management) system has been implemented countrywide for disease surveillance and case management. All diagnosed patients are individually recorded in this electronic register with a unique registration number, and all of their clinical data are captured here.

TB treatment outcomes are in accord with WHO recommendations and described in national guidelines \[[@pone.0128907.ref006]\].

Study population {#sec013}
----------------

The study population included all TB patients on first line treatment (new and retreatment cases) registered countrywide in the NTP between January 2006 and December 2010.

Data collection and analysis {#sec014}
----------------------------

All data pertaining to this study were sourced from the TB ESCM electronic register.

Patient characteristics were reported using summary statistics. Age categories were defined as follows: less than 15 years--child; 15--18 years--adolescent, 19--55 years--adult; 56 years or above--elderly. Unfavorable treatment outcomes were defined as death, treatment failure and lost to follow up, and each of these outcomes was assessed separately. Risk factors for unfavorable TB treatment outcomes were determined by crude odds ratios (ORs) and adjusted ORs, comparing the odds of having that outcome of interest with the odds of not having that outcome of interest (i.e. having any other outcome). Adjusted ORs were determined through multivariate logistic regression using a backward stepwise elimination approach until all remaining variables in the model were significant at *P* = 0.05 or less. All related *P*-values were based on the Walds test and 95% confidence intervals were used throughout. Due to the incomplete ascertainment of transfer outs (many of which were considered to be failures secondary to MDR-TB), a sensitivity analysis was run in which all transfer outs were assumed to be failures.

The study was carried out between June 2013 and June 2014 using EpiData Analysis software (version 2.2.2.182, EpiData Association, Odense, Denmark) and STATA/IC 11 software (Stata corporation, College Station, Texas 77845, USA).

Results {#sec015}
=======

Characteristics of the study population {#sec016}
---------------------------------------

Between 2006 and 2010, 110,146 TB patients on first-line drug regimen were registered in Uzbekistan. Of these, one percent (1226) had treatment outcome missing and 1.4% (1540) did not have a confirmed TB diagnosis; as such these patients were excluded from the analysis. [Table 1](#pone.0128907.t001){ref-type="table"} shows the baseline demographic and clinical characteristics of the 107,380 patients included in the study. Adults (19--55 years) made up 67% (71522) of the patients, while 10% (11519) were children (\<15 years) and 4% (4764) were adolescents (15--18 years). Almost 60% were male and 66% from rural areas (70705). New patients made up 75% (81016) of the caseload, while 25% (26364) were previously treated patients. One percent (984) of patients was human immunodeficiency virus (HIV) positive and less than one percent (586) had a history of imprisonment. Seventy seven percent (82686) of patients had pulmonary tuberculosis (PTB), of which 43% (35178) were sputum smear positive, 53% (44205) sputum smear negative and 3303 with no or unknown sputum results.

10.1371/journal.pone.0128907.t001

###### Socio-demographic and clinical characteristics and treatment outcomes of tuberculosis patients, Uzbekistan 2006--2010.

![](pone.0128907.t001){#pone.0128907.t001g}

  *Variables*                              n (%)
  ---------------------------------------- ------------
  **Total**                                **107380**
  **Age (years)**                          
  Children (\<15)                          11519 (11)
  Adolescent (15--18)                      4764 (4)
  Adults (19--55)                          71522 (67)
  Elderly patients (\>55)                  19575 (18)
  **Sex**                                  
  Male                                     63724 (59)
  Female                                   43656 (41)
  **Place of residence**                   
  Urban                                    32752 (30)
  Rural                                    70705 (66)
  Unknown                                  3923 (4)
  **Provinces**                            
  Republic of Karakalpakstan               13905 (13)
  Tashkent city                            8504 (8)
  Andijan province                         8525 (8)
  Bukhara province                         4857 (4)
  Jizzakh province                         4873 (5)
  Kashkadarya province                     8593 (8)
  Navoi province                           4258 (4)
  Namangan province                        8062 (8)
  Samarkand province                       11202 (10)
  Surkhandarya province                    5455 (5)
  Syrdarya province                        2601 (3)
  Tashkent province                        11314 (11)
  Fergana province                         9830 (9)
  Khorezm province                         5164 (5)
  Navoi mining company                     229 (\<1)
  Unknown                                  8 (\<1)
  **HIV status**                           
  HIV positive                             984 (1)
  HIV negative                             96524 (90)
  Unknown                                  9872 (9)
  **TB type**                              
  PTB                                      
  Smear positive                           35178 (33)
  Smear negative                           44205 (41)
  No sputum/no sputum result               3303 (3)
  EPTB                                     24694 (23)
  **History of TB treatment**              
  New cases                                81016 (75)
  Retreatment cases                        26364 (25)
  **Treatment category**                   
  0                                        93 (\<1)
  I                                        76548 (71)
  II                                       25986 (24)
  III                                      4752 (4)
  Unknown                                  1 (\<1)
  **History of contact with TB patient**   
  No                                       90673 (85)
  Yes                                      5590 (5)
  Unknown                                  11117 (10)
  **History of imprisonment**              
  No                                       44147 (41)
  Yes                                      586 (\<1)
  Unknown                                  62647 (58)
  **Occupational status**                  
  Worker                                   12105 (11)
  Jobless                                  48569 (45)
  Pre-school age                           2994 (3)
  Pupil/student                            11186 (10)
  Pensioner                                13898 (13)
  Handicapped                              5996 (6)
  Unknown                                  12632 (12)
  **Treatment outcomes**                   
  Cured                                    25404 (23)
  Treatment completed                      64218 (60)
  Died                                     5953 (6)
  Loss to follow up                        6768 (6)
  Failure                                  3312 (3)
  Transferred out                          1725 (2)

TB, Tuberculosis; PTB, Pulmonary TB; EPTB, Extrapulmonary TB.

Treatment outcomes and their trends {#sec017}
-----------------------------------

Overall, 83% (89622) of patients were successfully treated (cured or treatment completed), 6% (5953) died, 6% (6768) were lost to follow up, 3% (3312) failed treatment and 2% (1725) were transferred out. Trends in the different unfavorable outcomes between 2006 and 2010 are shown in [Fig 1](#pone.0128907.g001){ref-type="fig"}. Deaths and treatment failures have remained stable over time, while lost to follow up decreased from 7.8% in 2006 to 5.7% in 2010. [Table 2](#pone.0128907.t002){ref-type="table"} shows a breakdown of treatment outcomes by TB type and TB retreatment history. Of note, new smear positive cases had a treatment success rate of 82%, new EPTB cases had a treatment success rate of 93%, and retreatment cases had a treatment success rate of 73%.

![Unfavorable treatment outcomes over five years in Uzbekistan 2006--2010.](pone.0128907.g001){#pone.0128907.g001}

10.1371/journal.pone.0128907.t002

###### Treatment outcomes of all registered tuberculosis patients by TB type and treatment history, Uzbekistan 2006--2010.

![](pone.0128907.t002){#pone.0128907.t002g}

                            n        Treatment success n (%)   Diedn (%)   Treatment Failuren (%)   Lost to follow up n (%)   Transferred out n (%)
  ------------------------- -------- ------------------------- ----------- ------------------------ ------------------------- -----------------------
  **New cases**                                                                                                               
  sssssssssSmear positive   24480    19971 (82)                1437 (6)    1322 (5)                 1257 (5)                  493 (2)
  Smear negative            32240    28198 (87)                1513 (5)    405 (1)                  1750 (5)                  374 (1)
  No sputum/no result       1940     1572 (81)                 129 (7)     100 (5)                  101 (5)                   38 (1)
  Extrapulmonary            22356    20704 (93)                414 (2)     31 (0.1)                 1054 (5)                  153 (0.7)
  **Retreatment cases**     26364    19177 (73)                2460 (9)    1454 (6)                 2606 (10)                 667 (3)
  ***Total***               107380   89622 (83)                5953 (6)    3312 (3)                 6768 (6)                  1725 (6)

Factors associated with deaths, lost to follow-ups and treatment failures {#sec018}
-------------------------------------------------------------------------

Based on a multivariate analysis, factors found to be associated with death included being elderly (\>55), being male, living in an urban area, having smear positive PTB, having a history of TB treatment, being HIV positive and being jobless, a pensioner or handicapped. The three provinces with the highest mortality were Samarkand province, Surkhandarya province and Tashkent city, ([Table 3](#pone.0128907.t003){ref-type="table"}). Being a child or adolescent, and having EPTB, was protective for dying.

10.1371/journal.pone.0128907.t003

###### Factors associated with deaths among TB patients in Uzbekistan 2006--2010.

![](pone.0128907.t003){#pone.0128907.t003g}

  *Variable*                                                               n            Deaths n (%)       Crude OR (95% CI)               Adjusted OR[^a^](#t003fn002){ref-type="table-fn"} (95% CI)   *P*-value
  ------------------------------------------------------------------------ ------------ ------------------ ------------------------------- ------------------------------------------------------------ -----------
  **Total**                                                                107380       5953 (6)           \-                              \-                                                           \-
  **Age (years)**                                                                                                                                                                                       
  Children (\<15)                                                          11519        75 (1)             0.1 (0.09--0.1)                 0.3 (0.2--0.5)                                               \<0.001
  Adolescent (15--18)                                                      4764         96 (2)             0.4 (0.3--0.5)                  0.7 (0.5--0.9)                                               0.005
  Adults (19--55)                                                          71522        3759 (5)           1                               1                                                            
  Elderly patients (\>55)                                                  19575        2023 (10)          2.1 (2.0--2.2                   1.9 (1.6--2.1)                                               \<0.001
  **Sex**                                                                                                                                                                                               
  Male                                                                     63724        3855 (6)           1.3 (1.2--1.3)                  1.3 (1.2--1.4)                                               0.001
  Female                                                                   43656        2098 (5)           1                               1                                                            
  **Place of residence**                                                                                                                                                                                
  Urban                                                                    32752        2257 (7)           1.5 (1.4--1.6)                  1.3 (1.2--1.4)                                               \<0.001
  Rural                                                                    70705        3343 (5)           1                               1                                                            
  Unknown                                                                  3923         353 (9)            2.0 (1.8--2.2)                                                                               
  **Province**                                                                                                                                                                                          
  Rep. of Karakalpakstan                                                   13905        702 (5)            1.7 (1.4--2.0)                  1.1 (0.9--1.4)                                               0.40
  Tashkent city                                                            8504         849 (10)           3.5 (2.9--4.2)                  1.9 (1.5--2.4)                                               0.001
  Andijan province                                                         8525         399 (5)            1.5 (1.3--1.9)                  1.3 (1.0--1.6)                                               0.07
  Bukhara province                                                         4857         220 (4)            1.5 (1.2--1.9)                  1.1 (0.9--1.5)                                               0.31
  Jizzakh province                                                         4873         147 (3)            1.0 (0.8--1.2)                  0.9 (0.7--1.3)                                               0.69
  Kashkadarya province                                                     8593         279 (3)            1.1 (0.9--1.3)                  1.2 (0.9--1.5)                                               0.17
  Navoi province                                                           4258         131 (3)            1                               1                                                            
  Namangan province                                                        8062         361 (4)            1.4 (1.2--1.8)                  1.4 (1.1--1.8)                                               0.004
  Samarkand province                                                       11202        998 (9)            3.1 (2.6--3.7)                  2.3 (1.8--2.9)                                               0.001
  Surkhandarya province                                                    5455         295 (5)            1.8 (1.5--2.2)                  1.8 (1.4--2.3)                                               0.001
  Syrdarya province                                                        2601         144 (6)            1.8 (1.4--2.4)                  1.7 (1.3--2.3)                                               0.001
  Tashkent province                                                        11314        622 (6)            1.8 (1.5--2.2)                  1.6 (1.2--2.0)                                               0.001
  Fergana province                                                         9830         568 (6)            1.9 (1.6--2.3)                  1.5 (1.2--1.9)                                               0.001
  Khorezm province                                                         5164         228 (4)            1.5 (1.2--1.8)                  1.2 (0.9--1.5)                                               0.21
  Navoi mining company                                                     229          9 (4)              1.3 (0.6--2.6)                  1.3 (0.6--2.7)                                               0.50
  Unknown                                                                  8            1 (12)                                                                                                          
  **HIV status**                                                                                                                                                                                        
  HIV positive                                                             984          280 (29)           7.5 (6.5--8.7)                  8.1 (6.9--9.5)                                               \<0.001
  HIV negative                                                             96524        4852 (5)           1                               1                                                            
  Unknown status                                                           9872         821 (8.3)          1.7 (1.6--1.9)                                                                               
  **TB type**                                                                                                                                                                                           
  PTB                                                                                                                                                                                                   
  Smear positive                                                           35178        2875 (8)           1.6 (1.5--1.7)                  1.5 (1.5--1.7)                                               \<0.001
  Smear negative                                                           44205        2277 (5)           1                               1                                                            
  No sputum/no result                                                      3303         293 (9)            1.8 (1.6--2.0)                  1.6 (1.3--1.8)                                               \<0.001
  EPTB                                                                     24694        508 (2)            0.4 (0.4--0.4)                  0.7 (0.6--0.8)                                               \<0.001
  **History of TB treatment**                                                                                                                                                                           
  New cases                                                                81016        3493 (4)           1                               1                                                            
  Retreatment cases                                                        26364        2460 (9)           2.3 (2.2--2.4)                  1.7 (1.5--1.8)                                               \<0.001
  **Treatment category**                                                                                                                                                                                
  0[^b^](#t003fn003){ref-type="table-fn"}                                  93           13 (14)            3.4 (1.9--6.2)                                                                               
  I                                                                        76548        3454 (5)           1                                                                                            
  II                                                                       25986        2444 (10)          2.2 (2.1--2.3)                                                                               
  III                                                                      4752         42 (1)             0.2 (0.1--0.3)                                                                               
  Unknown                                                                  1            0 (0)                                                                                                           
  **History of contact with TB patient**                                                                                                                                                                
  No                                                                       90673        4892 (5)           1.5 (1.3--1.7)                                                                               
  Yes                                                                      5590         206 (4)            1                                                                                            
  Unknown                                                                  11117        855 (8)                                                                                                         
  **History of imprisonment** [^**c**^](#t003fn004){ref-type="table-fn"}                                                                                                                                
  No                                                                       44147        1893 (4)           1                                                                                            
  Yes                                                                      586          39 (7)             1.6 (1.1--2.2)                                                                               
  Unknown                                                                  62647        4021 (6)           1.5 (1.4--1.6)                                                                               
  **Occupational status**                                                                                                                                                                               
  Worker                                                                   12105        381 (3)            1                               1                                                            
  Jobless                                                                  48569        2476 (5)           1.7 (1.5--1.8)                  1.5 (1.4--1.7)                                               \<0.001
  Pre-school age                                                           2994         28 (1)             0.3 (0.2--0.4)                  1.0 (0.5--1.9)                                               0.96
  Pupil/student                                                            11186        82 (1)             0.2 (0.2--0.3)                  0.8 (0.6--1.1)                                               0.21
  Pensioner                                                                13898        1461 (11)          3.6 (3.2--4.1)                  2.1 (1.8--2.5)                                               \<0.001
  Handicapped Unknown                                                      5996 12632   585 (10) 940 (7)   3.3 (2.9--3.8) 2.5 (2.2--2.8)   2.4 (2.1--2.7)                                               \<0.001

TB, Tuberculosis; PTB, Pulmonary TB; EPTB, Extrapulmonary TB; OR, Odds Ratio, CI, Confidence Interval

^a^Adjusted odds ratios only presented for variables included in the multivariate model; 92812 records included in the multivariate model

^b^0- patients who refused treatment, or treatment category not defined, or where TB diagnosis was based on the findings of a post-mortem

^c^Data should not be considered relevant as unknown cases more than 50% in this group of patients

Factors associated with lost to follow-up were being male, living in an urban area, being HIV positive, having previous TB treatment history, being jobless, and living in the following provinces: Bukhara province, Tashkent province, Andijan province, **(** [Table 4](#pone.0128907.t004){ref-type="table"} **)**. Being an adolescent was protective for being lost to follow-up.

10.1371/journal.pone.0128907.t004

###### Factors associated with loss to follow-up among TB patients in Uzbekistan 2006--2010.

![](pone.0128907.t004){#pone.0128907.t004g}

  *Variable*                                                               N        Loss to follow up n (%)   Crude OR (95% CI)   Adjusted OR[^a^](#t004fn002){ref-type="table-fn"} (95% CI)   *P*-value
  ------------------------------------------------------------------------ -------- ------------------------- ------------------- ------------------------------------------------------------ -----------
  **Total**                                                                107380   6768 (6)                  \-                  \-                                                           \-
  **Age (years)**                                                                                                                                                                              
  Children (\<15)                                                          11519    455 (4)                   0.5 (0.5--0.6)      0.8 (0.6--1.0)                                               0.06
  Adolescent (15--18)                                                      4764     190 (4)                   0.5 (0.5--0.6)      0.7 (0.6--0.8)                                               \<0.001
  Adults (19--55)                                                          71522    5083 (7)                  1                   1                                                            
  Elderly patients (\>55)                                                  19575    1040 (5)                  0.7 (0.7--0.8)      0.9 (0.8--1.0)                                               0.11
  **Sex**                                                                                                                                                                                      
  Male                                                                     63724    4645 (7)                  1.5 (1.5--1.6)      1.4 (1.4--1.5)                                               \<0.001
  Female                                                                   43656    2123 (5)                  1                   1                                                            
  **Place of residence**                                                                                                                                                                       
  Urban                                                                    32752    2800 (9)                  1.8 (1.7--1.9)      1.8 (1.7--2.0)                                               \<0.001
  Rural                                                                    70705    3560 (5)                  1                   1                                                            
  Unknown                                                                  3923     408 (10)                  2.2 (2.0--2.4)                                                                   
  **Province**                                                                                                                                                                                 
  Republic of Karakalpakstan                                               13905    693 (5)                   1.4 (1.2--1.7)      0.9 (0.7--1.2)                                               0.54
  Tashkent city                                                            8504     528 (6)                   1.8 (1.5--2.1)      0.8 (0.6--1.0)                                               0.03
  Andijan province                                                         8525     722 (8)                   2.5 (2.1--2.9)      2.1 (1.6--2.6)                                               \<0.001
  Bukhara province                                                         4857     564 (12)                  3.5 (2.9--4.2)      3.3 (2.6--4.1)                                               \<0.001
  Jizzakh province                                                         4873     177 (4)                   1.0 (0.8--1.3)      1.0 (0.7--1.3)                                               0.83
  Kashkadarya province                                                     8593     239 (3)                   0.8 (0.6--0.9)      0.7 (0.6--0.9)                                               0.02
  Navoi province                                                           4258     154 (4)                   1                   1                                                            
  Namangan province                                                        8062     467 (6)                   1.6 (1.4--2.0)      1.4 (1.1--1.7)                                               0.01
  Samarkand province                                                       11202    585 (5)                   1.5 (1.2--1.8)      1.1 (1.1--1.7)                                               0.008
  Surkhandarya province                                                    5455     377 (7)                   2.0 (1.6--2.4)      1.8 (1.4--2.3)                                               \<0.001
  Syrdarya province                                                        2601     116 (5)                   1.2 (1.0--1.6)      1.0 (0.8--1.4)                                               0.93
  Tashkent province                                                        11314    1195 (11)                 3.1 (2.7--3.7)      2.4 (1.9--3.0)                                               \<0.001
  Fergana province                                                         9830     636 (7)                   1.8 (1.5--2.2)      1.6 (1.3--2.0)                                               \<0.001
  Khorezm province                                                         5164     300 (6)                   1.6 (1.3--2.0)      1.4 (1.1--1.8)                                               0.01
  Navoi mining company                                                     229      11 (5)                    1.3 (0.7--2.5)      1.1 (0.5--2.1)                                               0.85
  Unknown                                                                  8        2 (25)                    8.9 (1.8--44.4)                                                                  
  **HIV status**                                                                                                                                                                               
  HIV positive                                                             984      81 (8)                    1.5 (1.2--1.8)                                                                   
  HIV negative                                                             96524    5607 (6)                  1                                                                                
  Unknown                                                                  9872     1080 (11)                 2.0 (1.9--2.1)                                                                   
  **TB type**                                                                                                                                                                                  
  PTB                                                                                                                                                                                          
  Smear positive                                                           35178    2416 (7)                  1.1 (1.0--1.1)                                                                   
  Smear negative                                                           44205    2893 (7)                  1                                                                                
  No sputum/no result                                                      3303     277 (7)                   1.1 (0.9--1.2)                                                                   
  EPTB                                                                     24694    1232 (5)                  0.7 (0.7--0.8)                                                                   
  **History of TB treatment**                                                                                                                                                                  
  New cases                                                                81016    4162 (5)                  1                   1                                                            
  Retreatment cases                                                        26364    2606 (10)                 2.0 (1.9--2.1)      1.8 (1.7--1.9)                                               \<0.001
  **TB treatment category**                                                                                                                                                                    
  0[^b^](#t004fn003){ref-type="table-fn"}                                  93       7 (8)                     1.5 (0.7--3.3)                                                                   
  I                                                                        76548    3911 (5)                  1                                                                                
  II                                                                       25986    2580 (10)                 2.0 (1.9--2.2)                                                                   
  III                                                                      4752     270 (6)                   1.1 (1.0--1.3)                                                                   
  Unknown                                                                  1        0 (0)                     \-                                                                               
  **History of contact with TB patient**                                                                                                                                                       
  No                                                                       90673    309 (6)                   1.4 (1.3--1.5)                                                                   
  Yes                                                                      5590     5415 (6)                  1                                                                                
  Unknown                                                                  11117    1044 (9)                                                                                                   
  **History of imprisonment** [^**c**^](#t004fn004){ref-type="table-fn"}                                                                                                                       
  No                                                                       44147    2614 (6)                  1                                                                                
  Yes                                                                      586      62 (11)                   1.9 (1.4--2.5)                                                                   
  Unknown                                                                  62647    4092 (7)                  1.1 (1.1--1.2)                                                                   
  **Occupational status**                                                                                                                                                                      
  Worker                                                                   12105    531 (4)                   1                   1                                                            
  Jobless                                                                  48569    3492 (7)                  1.7 (1.5--1.9)      1.7 (1.6--1.9)                                               \<0.001
  Pre-school age                                                           2994     140 (5)                   1.1 (0.9--1.3)      1.5 (1.1--2.0)                                               0.02
  Pupil/student                                                            11186    399 (4)                   0.8 (0.7--0.9)      1.2 (0.9--1.5)                                               0.25
  Pensioner                                                                13898    674 (5)                   1.1 (1.0--1.2)      1.3 (1.1--1.6)                                               0.002
  Handicapped                                                              5996     423 (7)                   1.7 (1.5--1.9)      1.3 (1.1--1.5)                                               0.001
  Unknown                                                                  12632    1109 (9)                  2.1 (1.9--2.3)                                                                   

TB, Tuberculosis; PTB, Pulmonary TB; EPTB, Extrapulmonary TB; OR, Odds Ratio, CI, Confidence Interval

^a^Adjusted odds ratios only presented for variables included in the multivariate model; 92812 records included in the multivariate model

^b^0- patients who refused treatment, or treatment category not defined, or where TB diagnosis was based on the findings of a post-mortem

^c^Data should not be considered relevant as unknown cases more than 50% in this group of patients

Factors associated with treatment failure included being adolescent, urban area population, having positive sputum result, previous treatment history, being HIV negative, being jobless, and residing in the following provinces: Fergana province, Tashkent city, Republic of Karakalpakstan, ([Table 5](#pone.0128907.t005){ref-type="table"}). Being a child and having EPTB, was protective for failing treatment.

10.1371/journal.pone.0128907.t005

###### Factors associated with treatment failure in TB patients in Uzbekistan, 2006--2010.

![](pone.0128907.t005){#pone.0128907.t005g}

  *Variables*                                                              n (%)    Treatment failure n (%)   Crude OR (95% CI)   Adjusted OR[^a^](#t005fn002){ref-type="table-fn"} (95% CI)   *P*-value
  ------------------------------------------------------------------------ -------- ------------------------- ------------------- ------------------------------------------------------------ -----------
  **Total**                                                                107380   3312 (3)                                                                                                   
  **Age (years)**                                                                                                                                                                              
  Children (\<15)                                                          11519    32 (\<1)                  0.07 (0.05--0.1)    0.6 (0.3--0.9)                                               0.02
  Adolescent (15--18)                                                      4764     170 (4)                   0.9 (0.8--1.1)      1.3 (1.1--1.7)                                               0.01
  Adults (19--55)                                                          71522    2716 (4)                  1                   1                                                            
  Elderly patients (\>55)                                                  19575    394 (2)                   0.5 (0.5--0.6)      0.8 (0.7--1.0)                                               0.07
  **Sex**                                                                                                                                                                                      
  Male                                                                     63724    2070 (3)                  1.2 (1.1--1.2)                                                                   
  Female                                                                   43656    1242 (3)                  1                                                                                
  **Place of residence**                                                                                                                                                                       
  Urban                                                                    32752    1462 (5)                  2.0 (1.9--2.2)      1.5 (1.4--1.7)                                               \<0.001
  Rural                                                                    70705    1590 (2)                  1                   1                                                            
  Unknown                                                                  3923     260 (7)                   3.2 (2.7--3.5)                                                                   
  **Province**                                                                                                                                                                                 
  Rep of Karakalpakstan                                                    13905    682 (5)                   3.6 (2.7--4.5)      2.6 (1.9--3.7)                                               \<0.001
  Tashkent city                                                            8504     427 (5)                   3.6 (2.7--4.7)      2.1 (1.4--2.9)                                               0.001
  Andijan province                                                         8525     304 (4)                   2.5 (1.9--3.3)      1.9 (1.4--2.8)                                               \<0.001
  Bukhara province                                                         4857     78 (2)                    1.1 (0.8--1.5)      1.2 (0.8--1.8)                                               0.42
  Jizzakh province                                                         4873     61 (1)                    0.9 (0.6--1.2)      0.6 (0.4--0.9)                                               0.02
  Kashkadarya province                                                     8593     17 (\<1)                  0.1 (0.1--0.2)      0.1 (0.1--0.2)                                               \<0.001
  Navoi province                                                           4258     62 (2)                    1                   1                                                            
  Namangan province                                                        8062     181 (2)                   1.6 (1.2--2.1)      1.4 (1.0--2.0)                                               0.09
  Samarkand province                                                       11202    239 (2)                   1.5 (1.1--2.0)      1.4 (1.0--1.9)                                               0.09
  Surkhandarya province                                                    5455     79 (2)                    1.0 (0.7--1.4)      0.8 (0.5--1.1)                                               0.20
  Syrdarya province                                                        2601     85 (3)                    2.3 (1.6--3.2)      1.7 (1.1--2.5)                                               0.01
  Tashkent province                                                        11314    492 (4)                   3.1 (2.4--4.0)      2.1 (1.5--3.0)                                               \<0.001
  Fergana province                                                         9830     447 (5)                   3.2 (2.5--4.2)      2.8 (2.0--3.9)                                               \<0.001
  Khorezm province                                                         5164     151 (3)                   2 (1.5--2.7)        1.2 (0.8--1.8)                                               0.27
  Navoi mining                                                             229      6 (3)                     1.8 (0.8--4.3)      2.7 (1.1--6.5)                                               0.03
  Unknown                                                                  8        0 (0)                     \-                  \-                                                           
  **HIV status**                                                                                                                                                                               
  Positive                                                                 984      23 (2)                    1                   1                                                            
  Negative                                                                 96524    2656 (3)                  1.2 (0.8--1.8)      1.6 (1.1--2.5)                                               0.02
  Unknown                                                                  9872     635 (7)                   2.9 (1.9--4.4)                                                                   
  **TB type**                                                                                                                                                                                  
  PTB                                                                                                                                                                                          
  Smear positive                                                           35178    2482 (7)                  5.5 (5.0--6.0)      5.5 (4.9--6.0)                                               \<0.001
  Smear negative                                                           44205    606 (1)                   1                   1                                                            
  No sputum/no result                                                      3303     192 (6)                   4.4 (3.8--5.2)      4.3 (3.5--5.3)                                               \<0.001
  EPTB                                                                     24694    32 (0.1)                  0.09 (0.07--0.1)    0.2 (0.1--0.2)                                               \<0.001
  **History of TB treatment**                                                                                                                                                                  
  New cases                                                                81016    1858 (2)                  1                   1                                                            
  Retreatment cases                                                        26364    1454 (6)                  2.5 (2.3--2.7)      1.7 (1.5--1.8)                                               \<0.001
  **Treatment category**                                                                                                                                                                       
  0[^b^](#t005fn003){ref-type="table-fn"}                                  93       1 (1)                     0.4 (0.06--3.1)                                                                  
  I                                                                        76548    1856 (2)                  1                                                                                
  II                                                                       25986    1447 (6)                  0.07 (0.03--0.1)                                                                 
  III                                                                      4752     8 (0.2)                   \-                                                                               
  Unknown                                                                  1        1 (0)                                                                                                      
  **TB contact**                                                                                                                                                                               
  No                                                                       90673    2425 (3)                  1.6 (1.4--1.8)      1.6 (1.4--1.8)                                               \<0.001
  Yes                                                                      5590     887 (6)                   1                   1                                                            
  Unknown                                                                  11117    0 (0)                                                                                                      
  **History of imprisonment** [^**c**^](#t005fn004){ref-type="table-fn"}                                                                                                                       
  No                                                                       44147    1037 (2)                  1                                                                                
  Yes                                                                      586      19 (3)                    1.4 (0.9--2.2)                                                                   
  Unknown                                                                  62647    2256 (4)                  1.6 (1.4--1.7)                                                                   
  **Occupational status**                                                                                                                                                                      
  Worker                                                                   12105    345 (3)                   1                   1                                                            
  Jobless                                                                  48569    1712 (4)                  1.3 (1.1--1.4)      1.1 (1.0--1.3)                                               0.03
  Pre-school age                                                           2994     1 (0.03)                  0.01 (0.002--0.8)   0.1 (0.01--0.8)                                              0.03
  Pupil/student                                                            11186    103 (0.9)                 0.3 (0.3--0.4)      0.9 (0.6--1.2)                                               0.37
  Pensioner                                                                13898    225 (2)                   0.6 (0.5--0.7)      0.7 (0.5--0.9)                                               0.005
  Handicapped                                                              5996     247 (4)                   1.5 (1.2--1.7)      1.1 (0.9--1.3)                                               0.22
  Unknown                                                                  12632    679 (6)                   2 (1.7--2.3)        \-                                                           \-

TB, Tuberculosis; PTB, Pulmonary TB; EPTB, Extrapulmonary TB; OR, Odds Ratio, CI, Confidence Interval

^a^Adjusted odds ratios only presented for variables included in the multivariate model; 92055 records included in the multivariate model

^b^0- patients who refused treatment, or treatment category not defined, or where TB diagnosis was based on findings of a post-mortem

^c^Data should not be considered relevant as unknown cases more than 50% in this group of patients

Discussion {#sec019}
==========

This is the first report from Uzbekistan, and one of the first from a former Soviet Union Country, describing the association of risk factors with treatment outcomes of the patients under first-line drug regimen over the course of five years. Systematic reviews have highlighted that there are limited large-scale data on TB treatment outcomes. Another systematic review of national-level TB treatment outcomes among the 30 European Union /European Economic Area countries indicated the same \[[@pone.0128907.ref009]\]. The WHO Global TB Report provide such data at national level; however detailed analysis of individual patient data, as well as associations between unfavorable treatment outcomes and selected demographic and clinical characteristics, are not reported \[[@pone.0128907.ref005]\].

Our study has shown promising treatment success (83%) among registered TB patients on first line treatment in Uzbekistan, with these data closely corroborating the data on treatment outcomes reported by WHO for Uzbekistan \[[@pone.0128907.ref005]\]. The overall treatment success rate that we report is marginally higher that reported by WHO because WHO only considers new smear positive cases in its analysis, whereas we have reported on all registered patients. This includes new smear negative and EPTB cases who have higher rates of treatment success than new smear positive cases. Moreover, we have been able to describe in detail patient characteristics together with certain factors that are associated with unfavorable treatment outcomes. These findings may help the national programme to define strategies and targeted interventions for the most vulnerable populations in order to further improve TB control.

Trends in unfavorable TB outcomes remained relatively stable over the five year period. Interestingly however, despite stable treatment failure rates, a recent DRS survey revealed alarmingly high rates of DR TB among new and previously treated cases \[[@pone.0128907.ref003]\]. Various factors may underpin this situation, including low case detection rate. Recent estimates presented in the latest WHO Global TB Report \[[@pone.0128907.ref005]\] suggest that only 50% of TB cases in Uzbekistan are being detected and put on 'registered' treatment. This indicates that a large number of TB cases are either going untreated or, due to factors such as stigma, are seeking treatment from 'unofficial' sources, the latter of which may be associated with patients receiving inefficacious treatment regimens. We can only speculate, but 'unregistered' cases may be a prime driver of the MDR-TB epidemic and this calls for urgent measures to improve case detection in Uzbekistan. In the context of Uzbekistan, this could be addressed by a) strengthening the capacity of primary health care facilities in TB case detection, given that these facilities are usually the first point of contact for most patients; b) improving the performance of microscopy laboratories located in rural places; c) raising community awareness on TB. During the study period, access to MDR-TB diagnosis and treatment was only guaranteed for patients residing in Tashkent city, Nukus city and in penitentiary system. It is encouraging to see that since 2013, MDR-TB treatment has become available for everyone in the country and, since 2014, Xpert MTB/RIF has become available in all provinces.

In our analysis we went beyond the usual convention of just stratifying patients according to whether they were adults or children, and also considered adolescents (15--18 years) and elderly patients (\>55 years)--two groups that are rarely examined despite there being evidence that these are particularly vulnerable sub-groups in the context of other diseases \[[@pone.0128907.ref010]\]. In our study, adolescents had a higher likelihood of treatment failure and elderly patients had higher mortality. The latter has been reported in other settings \[[@pone.0128907.ref011],[@pone.0128907.ref012],[@pone.0128907.ref013]\] and may be due to age-related factors such as co-existing morbidities, like diabetes mellitus (which has been shown to increase the case fatality rate during TB treatment) \[[@pone.0128907.ref014]\], immunosuppression and a greater likelihood of unfavorable drug reactions \[[@pone.0128907.ref015],[@pone.0128907.ref016]\].

The degree of unfavorable treatment outcomes between provinces varied quite notably, with higher mortality, lost to follow-up and treatment failure observed in the capital city Tashkent, Fergana, and in the Republic of Karakalpakstan which is also known to have the highest rate of drug-resistant TB in the world \[[@pone.0128907.ref003], [@pone.0128907.ref017], [@pone.0128907.ref018]\]. The differences between provinces may be explained by a number of factors such as i) variations in drug resistance prevalence and resistance patterns (for example, the highest rates of MDR-TB have been reported in the Republic of Karakalpakstan \[[@pone.0128907.ref003]\] which in turn, is the province with the highest treatment failure; in contrast, the lowest rates of MDR-TB are reported in Surkhandarya province which concordantly has a relatively low odds of treatment failure compared with other provinces, ii) the performance of the local programme in terms of directly observed treatment (DOT) management, (i.e. poor supervision at the primary health facilities of patients' anti-TB drug intake during the continuation phase of treatment), iii) the performance of the local primary health care services in relation to TB case detection of TB through microscopy, iv) the availability of first and second line anti TB drugs on the open market (which may be inappropriately used by doctors (private and public based) who are treating 'unregistered' TB patients (NB. This is forbidden by national regulations) \[[@pone.0128907.ref006]\], and/or v) patient characteristics such as migration and population mobility. Operational research at the level of the province may help to identify these specific factors. Qualitative research methods in particular (such as direct observation, in-depth interviews with local key stake holders, and "content analysis" of local reports and archives), may provide additional information that quantitative data currently do not reveal. We have hypothesized several factors; of these, differences in performance between provinces, availability of TB-drugs on the "open market", and migration and mobility patterns, could be explored with qualitative or mixed methods.

There were disparities across all unfavorable outcomes when comparing urban and rural areas. This finding has not been reported in other similar settings and thus we can only speculate on possible reasons for it. Deaths, lost to follow-ups, and treatment failures were all more common among urban than rural patients. Possible reasons for this may be related to differences in patients and/or differences in TB control activities between urban and rural areas. Co-morbidities such as diabetes mellitus may be more prevalent in urban rather than rural communities \[[@pone.0128907.ref019]\], the latter of which is known to be associated with a higher likelihood of unfavorable TB outcomes \[[@pone.0128907.ref020]\]. Identifying what these specific reasons are would require further investigation.

As shown in previous studies \[[@pone.0128907.ref021], [@pone.0128907.ref022], [@pone.0128907.ref023]\], treatment outcomes were worse among HIV-positive TB patients compared to HIV negative TB patients, especially death. In contrast, HIV-positive TB patients had lower lost to follow-up and treatment failure. This could be partially accounted for by the higher mortality among HIV positive TB patients--i.e. these patients are more likely to die before it becomes evident that they have been lost to follow-up or failed treatment \[[@pone.0128907.ref024]\]; it may also reflect better adherence to treatment among these patients. It is important to note that HIV-testing uptake was high in this national TB cohort and the country should maintain and further improve this, even though Uzbekistan is a low prevalence country.

Our study shows that treatment outcomes are poor among pulmonary sputum positive cases, and among previously treated patients rather than patients with negative sputum results and new TB cases. Our findings reflect what many other studies have shown. \[[@pone.0128907.ref025], [@pone.0128907.ref026]\]

The main strength of the study relates to the large countrywide size and national representativeness of the data. It is one of the first studies to have used countrywide TB data to assess risk factors associated with unfavorable treatment outcomes, and to have analyzed individual patient data rather than aggregate data. Most national TB programmes report only aggregate data as maintaining electronic databases that collect individual patient data is too resource demanding.

There are several study limitations. First, the study was reliant on routinely collected data which may have been subject to reporting errors typically encountered in programmatic settings (such as incomplete data, inaccurate data, typing errors etc.). Second, we were not able to analyze some particularly interesting subgroups of patients such as inmates, as large amounts of these data were incomplete. Finally, a major limitation was the misclassification of 'transfer-outs'. Between 2003 and 2005, two MDR-TB pilot programmes were started in Karakalpakstan and the capital city Tashkent. Patients diagnosed with MDR-TB were transferred to the pilot clinics and their records were transferred to the MDR-TB register. In many instances, these patients were classified in the national database as "transferred out" rather than "treatment failure". Furthermore, for patients who were transferred out to a different distict/province, the national database should have been updated to reflect the final outcome for that patient. This however never happened. Therefore, in this study the outcome "transferred out" consisted of patients for whom the final outcome was not ascertained and patients who were transferred into the MDR TB register after failing standard treatment. As such, a proportion of the transfer outs were essentially treatment failures, although this proportion remains unknown. To take account of this discrepancy we ran a sensitivity analysis in which all transfer outs were considered to be failures. When transfer-outs were combined with failures like this however, there were no notable differences in the factors associated with this combined outcome in comparison to those factors identified as being associated with treatment failure alone. This misclassification in standard treatment outcome reporting needs to be addressed going forwards.

In conclusion, this study has demonstrated how countrywide data can be used to monitor trends in TB outcomes and guide the NTP in identifying areas where targeted strategies need to be deployed for vulnerable groups and in certain parts of the country. We also highlight the need to unify the monitoring and reporting of TB outcomes between the national database for standard TB treatment and the database for MDR-TB. Finally, as migration between countries continues to increase surveillance of treatment failures and coordination of TB case management between neighboring countries needs to be reinforced.
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